3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Lymphoma, Large B-Cell, Diffuse
29
Prostatic Neoplasms
28
Lymphoma, Follicular
15
Leukemia
15
Lymphoma, Non-Hodgkin
13
Hodgkin Disease
11
Burkitt Lymphoma
10
Leukemia, Biphenotypic, Acute
8
Recurrence
6
Neoplasms
6
Neoplasm Metastasis
6
Lymphoma, Large-Cell, Anaplastic
6
Lymphoma, B-Cell
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Immunoblastic Lymphadenopathy
4
Hemangioma
4
Dendritic Cell Sarcoma, Interdigitating
4
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, B-Cell, Marginal Zone
3
Breast Neoplasms
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurotoxicity Syndromes
2
Neoplasm, Residual
2
Interventions
Endoscopy
13
Endoscopy, Digestive System
12
Radiofrequency Ablation
7
Esomeprazole
7
Biopsy
7
Endoscopic Mucosal Resection
6
Specimen Handling
4
Proflavine
4
Omeprazole
4
Aspirin
4
Gastroscopy
3
YF 476
2
Proton Pump Inhibitors
2
Photochemotherapy
2
Narrow Band Imaging
2
Microscopy, Confocal
2
Metformin
2
Lansoprazole
2
Itraconazole
2
Endoscopes
2
Diagnostic Imaging
2
Dexlansoprazole
2
Cryotherapy
2
Cryosurgery
2
Breath Tests
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
rofecoxib
1
polyphenon E
1
plecanatide
1
omeprazole, sodium bicarbonate drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Barrett Esophagus
×
Prednisolone
×
Clear all
NCT02004782
2025-03-27
BERST
Western Sydney Local Health District
Phase 4
Withdrawn